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Genes located in the I region of the murine major histocompatibility complex (H- 
2)  regulate  specific  immune  responses  to  a  number  of antigens  (1,  2).  Immune 
response-associated (Ia) molecules found on most B cells, and to varying degrees on 
macrophages and T cells, are coded by genes in the 1-A and 1-E subregions and might 
well be the products of immune response (Ir) 1 and immune suppressor (Is) genes (2- 
5). Gene products of the I-J subregion, on the other hand, are found on suppressor T 
(Ts)  cells and their soluble factors (TsF) as well as on some helper T  cells (Th) and 
macrophages, all of which are intimately involved in the regulation of the immune 
response  (6). Due in part to a  relatively higher degree or frequency of expression, a 
great deal of information has been amassed as to the function, serology, and biochem- 
istry ofl-A  and I-E molecules (3, 4). In contrast, the low frequency (~5%) with which 
I-J-bearing cells are found in normal cells populations and the difficulty in producing 
anti-I-J alloantisera (7) have severely limited similar studies of 1-J gene products. 
1-,] gene products affect the immune response profoundly. Tada et al.  (8)  showed 
that a TsF specific for keyhole limpet hemocyanin (KLH) bears determinants encoded 
by the 1-J subregion. These findings were subsequently confirmed by Theze et al. (9) 
for a poly(GluU~'l'yrt'~)(GT)-specific  TsF and by Greene et al. (10) for an azobenzene 
arsonate-specific TsF. Pierres et al. (11,  12) demonstrated that the administration of 
microliter quantities of anti-I-J serum to GT-suppressor strain mice allowed them to 
make a  GT-specific antibody response apparently due to the elimination or inacti- 
vation of I-J-bearing Ts. Likewise, Greene et al. (13) showed that alloanti-I-J, when 
administered to S1509a  fibrosarcoma-bearing mice, caused regression of the tumor 
due to the inactivation of tumor-induced Ts. In addition, Tada et al.  (14) demon- 
strated that KLH-specific Ts bear antigenic determinants distinct from those found 
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on  I-J  +  Th,  suggesting  that  at  least  two  distinct  genes  are  located  within  the  l-J 
subregion. It may well be that the 1-J subregion is composed of a cluster of regulatory 
genes whose products are selectively expressed on Ts, Th, and macrophages. Although 
cell  absorbtion  studies  have been  useful  in  the  identification  of differing 1-J  gene 
products, critical evaluation of the heterogeneity of the 1-J subregion genes and their 
products  is limited when  aUoantisera are used.  The introduction  of somatic B  cell 
hybridization technology has allowed the production of large quantities of monoclonal 
antibodies (mAb). These monospecific antibodies should allow the further elucidation 
of the function and biochemistry of Ia molecules. 
In this paper I  report the preparation and properties of a  series of mAb directed 
against gene products of the I-J b and 1-J k subregions. These mAb were selected for 
their functional effect(s) upon normal spleen cell populations: first, for their ability to 
allow GT-suppressor mice to respond to GT immunization both in vitro and in vivo, 
and subsequently for their ability to bind GT-TsF of the appropriate haplotype. Some 
mAb bind GT-TsF, indicating a  heterogeneity of 1-J gene products. In addition,  an 
I-J  k monoclonal GT-TsF (mGT-TsF) has been produced that is specifically bound by 
anti-I-J  k mAb. The implications of these findings and reagents to the further char- 
acterization of the 1-J subregion and its products are discussed. 
Materials and Methods 
Mice.  BALB/c  (H-2 a)  and  AKR/Cum  (H-2 k)  mice were purchased  from Cumberland 
View Farms, Clinton, Tenn. C57BL/6 (B6, H-2b), C57BL/10 (B10, H-2b), and B10.BR (H-2 k) 
mice were obtained  from The Jackson Laboratory, Bar Harbor, Maine.  Breeding pairs of 
B10.A(3R)  (3R, H-2 i3) and B10.A(5R)  (5R, H-2 in) were the gift of Dr. N. Ponzio, Department 
of Microbiology-Immunology, Northwestern  University.  (DBA/2  ×  3R)F1 and  (DBA/2  × 
5R)FI mice were bred in our animal facilities. Mice used were 8-12 wk of age at the initiation 
of these experiments and were maintained on standard laboratory chow and water ad lib. 
Antigens.  Poly(GluS°TyrS°)(GT), lot 9, originally purchased from Miles Laboratories, Inc., 
Elkhardt,  Ind.,  was  the  generous  gift  of Dr.  Baruj  Benacerraf,  Harvard  Medical  School. 
Poly(Glun°Alan°TyrW)(GAT),  lot  1,  and  methylated  bovine  serum  albumin  (MBSA)  were 
purchased from Vega-Fox Bioehemieals  Div., Newberg Energy Corp., Tucson, Ariz. GAT, GT, 
and their MBSA complexes were prepared as previously described (15). 
Alloantisera.  Alloantisera to the I-J k subregion were prepared by injecting (DBA/2 × 3R)FI 
mice biweekly with 107 spleen and thymus cells from 5R female mice. Anti-I-J  b were similarly 
prepared by injecting (DBA/2 × 5R)F1 mice biweekly with 107 lymphoid cells from female 3R 
mice. In the preparation of both types of alloantisera, recipient mice were bled following the 
seventh biweekly immunization and were immunized and bled on alternate weeks thereafter. 
Production of Hybridomas.  B cell hybridomas secreting  anti-I-J antibodies were derived from 
the somatic cell  fusion  of hyperimmune spleen  cells with the hypoxanthine phosphoribosyl 
transferase-negative myeloma cell line, P3X63Ag8.  Briefly, a single cell suspension  of (DBA/2 
× 3R)Fs spleen cells was prepared 13 d after the 12th biweekly immunization of these F1 mice 
with  10  7 5R lymphocytes. 39 ×  106 (DBA/2 ×  3R)F1 hyperimmune spleen cells were admixed 
with 3.9 ×  10  e P3X63Ag8  myeloma cells in serum-free Duibecco's minimum essential medium 
(DME) and centrifuged into a loosely packed pellet.  1 ml of polyethylene glycol (PEG, diluted 
to 50% [vol/vol] with serum-free DME) was added dropwise to fuse the cell membranes (16). 
The fusion  mixture was diluted to 50 ml with serum-free DME over 15 rain.  The cells were 
washed to remove the PEG, resuspended to 30 ml in DME plus  10% fetal calf serum (FCS), 
and dispensed  into 96-well mieroculture plates (Linbro Chemical Co., Hamden, Conn.; 76-003- 
05)  to a  total of 384 wells. Each well received  5 ×  104 normal spleen  cells from (DBA/2  × 
3R)F1  mice as  "feeder" cells. The cultures were  incubated  for 48  h  at  37°C  in  10% CO2. 
Hybridoma cells were positively selected by elimination of the parent myeloma using hypoxan- 
thine-aminopterin-thymidine (HAT)-containing selective medium (17). Cultures were fed every 1572  ANTI-I-J MONOCLONAL ANTIBODIES 
other day by one-half medium replacement with HAT-DME plus 10% FCS for 7 d, followed 
by HT-DME plus 10% FCS for 7 d, and, finally, the cells were maintained in DME plus 10% 
FCS. Approximatel~ 95% of the seeded wells showed cellular growth a'fter the HAT-selection 
procedure.  Anti-I-J -secreting hybridomas were  similarly prepared  from  the  fusion  of 3R- 
immunized  (12th  immunization)  (DBA/2  ×  5R)F1  spleen  cells with  P3X63Ag8.  Anti-I-J- 
secreting hybrids were selected as detailed in  Results. Selected cell lines were established as 
monocional by the isolation of individual colonies in soft agar, as previously described (18). At 
various stages of the selection procedure, hybrid cell lines were cryopreserved in 2-ml aliquots 
containing no less than  106 viable cells/ml in DME plus 20% FCS plus 10% dimethylsulfoxide 
and stored at -85°C. 
T  cell hybridomas producing GT-TsF were prepared in a manner similar to that described 
above for the B cell hybridomas. In brief, B10.BR (H-2k,I-J k) mice were primed i.p. 4 d before 
fusion with  100 #g GT in aluminum-magnesium hydroxide gel (Maalox, Wm. F. Rorer, Ft. 
Washington,  Pa.).  170  ×  106  GT-primed  B10.BR  spleen  cells were  fused  with  8.4  ×  106 
BW5147.G. 1.4 (HAT-sensitive AKR thymoma cells obtained from the Cell Distribution Center, 
Salk Institute, San Diego, Calif.) cells. The HAT selection procedure was similar to that used 
for the selection of B cell hybrids, as outlined above, and will be described in further detail in 
a forthcoming report. 
Preparation of GT-TsF.  GT-TsF was  prepared  as  previously described  (19-21).  In  brief, 
BALB/e, B10.BR, or B6 mice were primed with 100 #g GT in Maalox i.p. 3-7 d before use. A 
single-cell suspension was prepared of the spleens and thymuses of these animals, washed once 
in Hanks' balanced salt solution (HBSS), resuspended to 6 ×  10  s cells/ml and sonicated (50 W 
for  5  rain)  by  a  Sonifier Cell  Disrupter equipped  with  a  mierotip  (Ultrasonic Industries, 
Westbury, N. Y.). Sonieated material was centrifuged at 40,000 g for 45 min at 4°C. GT-TsF- 
containing supernates were stored at -85°C until used. 
Preparation and Use of Immunoadsorbent Columns.  Immunoadsorbent columns were prepared as 
previously described (20).  Hybridoma culture supernates or ascites fluids from  hybridoma- 
bearing mice were heat inactivated for 30 rain at 56°C. Immunoglobulin-rich fractions were 
prepared by precipitation with 50% ammonium sulfate and extensively dialyzed against 0.5 M 
NaC1-0.1  M NaCOa. The globulin-rich fractions were coupled to CNBr-activated Sepharose 4B 
(Pharmacia  Fine Chemicals, Div. of Pharmaeia,  Inc.,  Piscataway, N. J.)  at  a  final protein 
concentration  of 2  mg/ml  packed  gel.  In  all cases,  coupling efficiency, as judged  by  UV 
absorbtion, was  >90%.  Immunoadsorbents  were stored  in  phosphate-buffered saline  (PBS) 
containing 0.2% NaNa. Before use, gels were packed in 3-ml plastic syringes to serve as columns 
and washed with 10-25 vol of PBS in the absence of azide. GT-TsF, diluted 1:10, was applied 
to the columns always in a  volume equal to or less than one-half the void volume of the gel. 
The GT-TsF were incubated in the gel bed for 15 min at 24°C, fresh PBS was applied to the 
column, and the effluent was collected. Columns were then washed with at least 10 vol of PBS, 
0.1 M glycine-HC1 buffer, pH 2.5, applied to the column, and the acid eluate was collected and 
immediately neutralized to pH 7.1-7.3 with the appropriate quantity of 2 M Tris. Effluent and 
eluate materials were immediately filter sterilized (0.45-#m filter) and added to Mishell-Dutton 
cultures at the final concentrations indicated in Tables I and III. In one series of experiments, 
an anti-idiotype immunoadsorbent column was used. This column was the generous gift of Dr. 
S.-T. Ju and Dr. M. E. Dorf, Department of Pathology, Harvard Medical School. Anti-idiotype 
antibodies (anti-CGAT) (22) for the common anti-GAT idiotype were bound to CNBr-aetivated 
Sepharose 4B at  1 mg protein/ml packed gel. Adsorptions and elutions from the column were 
performed exactly as described above. 
Immunizations.  AKR/Cum and B10.BR  mice were immunized with  10 p.g GT in Maalox 
and Bordetella pertussis i.p. as adjuvant immediately after intravenous injection of monoclonal 
anti-I-J antibodies. 7 d later the number of GT-specific plaque-forming cells (PFC) per spleen 
were determined. 
In Vitro Cultures.  Spleen cells ofBALB/c, AKR/Cum, B6, B10, or BI0.BR mice were placed 
in a modified Mishell-Dutton culture system. In brief, 8 X  10  e spleen cells were cultured for 5 
d  in 0.5-ml cultures in a  24-well tissue culture plate (Linbro 76-033-05)  in standard Mishell- 
Dutton  culture medium  (23)  containing 5  X  10  -s M  2-mercaptoethanol and  10%  FCS  (lot 
2851, Pel-Freez Biologicals Inc., Rogers, Ark.). 5 #g GAT, 10 #g GT, or 10 #g GT as GT-MBSA CARL  WALTENBAUGH  1573 
were added  at  culture  initiation. Alloanti-I-J antisera, hybridoma culture supernates,  ascites 
fluids  from  hybridoma-bearing  mice,  and/or  GT-TsF  was/were  added  as  indicated  in  the 
figures and the table legends. Cultures were fed daily with 120 #1 of a mixture of 50% nutritional 
cocktail and 50% FCS.  Cultures were incubated at 37°C  with rocking in a  moist atmosphere 
containing 83% N2,  10% CO2, and 7% 02. 5 d  after the establishment of culture, the number of 
GT-specific PFC per culture was enumerated. 
Hemolytic  Plaque Assay.  The  anti-GAT  and  anti-GT  PFC  response  was  assayed  by  a 
modification of the Jerne hemolytic plaque technique (20).  Indicator cells were prepared by 
coupling GAT  to sheep  erythrocytes  by  the CrC13  method.  Data  obtained  are  expressed  as 
number of PFC per spleen or PFC per culture. 
Results 
Effect  of Anti-I-J  Alloantisera In  Vitro.  In  our  laboratory  we  are  studying  the 
regulatory role(s) of I-J gene products expressed selectively on different macrophage 
and lymphoid cell populations. To this end, we have produced a panel of monoclonal 
antibodies  (mAb)  to gene products of the I-J subregion. The major obstacle to the 
identification of mAb  directed against  I-J  gene products by the microcytotoxicity 
assay  is  the  low  frequency with  which  I-J-bearing cells  are  found  in  normal  cell 
populations (7). We decided not to use selected Ts or I-J-bearing tumor cell popula- 
tions because this might not have expressed a  full repertoire of I-J specificities and, 
consequently, might have skewed our results by allowing us to detect only a  limited 
subset of mAb directed against I-J specificities. Instead, we chose to use a functional 
assay  to  screen  for  anti-I-J  mAb.  Although  the  binding  of TsF  to  an  anti-I-J 
immunoadsorbent column was one of the criteria originally used to identify I-J gene 
TABLE  I 
Effect of Anti-I-J Alloantisera on the Anti-CA T and Anti-GT PFC Responses 
of C57BL/6 and BIO.BR Spleen Cells In  Vitro 
Strain  Antigen*  Alloantiserum~ 
C57BL/6 (H-2 b) 
B10.BR (H-2 k) 
Antigen- 
specific 
PFC per 
culture§ 
* 5 #g of GAT or  10 #g of GT was added at culture initiation. Spleen cells 
were cultured for 5 d at 8 ×  l0  6 ceils per 0.5 ml in Mishell-Dutton culture 
medium containing 5 ×  10  -5 M/~-mercaptoethanol. 
:[: Alloantisera were  prepared  as  described  in  Materials  and  Methods  and 
added to cultures at the indicated final dilutions at culture initiation. 
§ Total PFC response on day 5 after culture initiation. 
GAT  None  285 
GAT  Anti-I-J  b 1:200  750 
GAT  Anti-I-J  b 1:400  412 
GAT  Anti-I-J  b 1:800  337 
GAT  Anti-I-J  k 1:200  158 
GAT  Anti-I-J  k 1:400  195 
GT  None  <20 
GT  Anti-I-J  b 1:400  <20 
GT  Anti-I-J  b 1:800  390 
GT  Anti-I-J  b 1  : 1,600  160 
GT  Anti-I-J  k 1:400  1,535 
GT  Anti-I-J  k 1:800  1,305 
GT  Anti-I-J  k 1  : 1,600  1,265 
GT  Anti-I-J  k 1:3,200  325 1574 
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i 
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C,T 'l[i, 
None  AI-A12  I  I,i 
B2-B12  ilLIhl 
c,-c,2  I  o,-o,11EI-E2 
HYBRIDOI4A CULTURE SUPERNATANTS AIX)ED TO CULTURE 
Fro.  1.  In vitro augmentation of GT-specific PFC by hybridoma  culture supernates. AKR/Cum 
spleen cells were placed in Mishell-Dutton-type culture conditions for 5 d in the presence of 10 #g 
GT/culture well and 25 #1 of WF8 series culture supernates were added to cultures at a 1:400 final 
dilution. The letter-numbers designate the hybridoma. The asterisk above the vertiele bar denotes 
the cell lines whose supernates were tested for their ability to bind GT-TsF, Table II, experiment I. 
products (8), the large number of hybrids obtained from a somatic B cell fusion makes 
this type of initial screening approach both costly and difficult to perform. Therefore, 
we asked whether anti-I-J antibody would augment PFC response in vitro. B6 (I-J b) 
spleen cells were placed in Mishell-Dutton-type cultures with suboptimal concentra- 
tion  (5 #g/ml)  of GAT (Table I). The addition of anti-I-J  b alloantiserum at a  final 
concentration of 1:200 to 1:400 caused a marked augmentation of the anti-GAT PFC 
response. Anti-I-J  k alloantiserum, on the other hand, caused no enhancement of the 
B6 anti-GT PFC response.  B10.BR (I-J k)  spleen cells  normally are unresponsive to 
GT in vitro (9). The addition of anti-I-J  k antibodies to cultures of B 10.BR spleen cells 
causes  a  marked  increase  in  the  number  of anti-GT  PFC  (Table  I),  whereas  the 
addition of anti-I-J  b antibody caused only minimal enhancement. This provided us 
with a rapid and simple method for the detection of anti-I-J activity. 
Effect of Hybridoma Culture Supernates In  Vitro.  Anti-I-Jk-secreting hybridoma cell 
lines were derived from the fusion of hyperimmune (DBA/2 ×  3R)Fx anti-5R spleen 
cells with the P3X63Ag8 myeloma cell line, as described in Materials and Methods. 
Initial screening for anti-I-J-secreting hybridomas utilized an X-Y coordinate system. 
In brief, two 96-well culture plates containing hybrid B cells  were arranged to form 
a grid of 12 vertical columns and 16 horizontal rows.  12 X-axis pools were made, each 
pool containing 20 #1 of culture supernate from each well in an individual column. 
Similarly, 16 Y-axis pools were made, each containing 15/d of culture supernate from 
each well of an individual row. 20 #1 from each X-axis pool or 15 #1 from each  Y-axis 
pool was added to individual 0.5-ml Mishell-Dutton-type cultures of AKR/Cum (/- 
jk)  spleen cells;  in  addition,  each culture contained  10 #g of GT.  Each  individual 
hybridoma culture supernate was thus tested at a  1:400 final dilution.  Positive (i.e., 
GT-response) cultures were identified by matching positive X-Y coordinates, and 47 
putative  anti-I-J-secreting  hybridomas  were  isolated.  These  47  hybridomas  were 
expanded  in  16-ram  tissue  culture  wells  and  assigned  letter-number  designations. 
Supernates from these wells were used for the second screening phase. 2-d-old culture CARL  WALTENBAUGH 
TABLE  II 
Adsorption  of GT-TsF by Monoclonal Anti-l-J Antibodies  Bound to Sepharose 
1575 
Immuno- 
adsorbentS: 
GT-specific PFC per culture* 
Untreated  Effluent§  Eluate[[ 
Experiment I: test for anti-I-J  k activity in WF8 series 
Control GT-MBSA response  --  1,510  --  -- 
B 10.BR (1-1-2  k) GT-TsF  --  <20  --  -- 
B10.BR (H-2 k) GT-TsF  WF8.A12  852  <20 
B10.BR (H-2 k) GT-TsF  WF8.B2  <20  777 
BI0.BR (H-2 k) GT-TsF  WF8.B6  1,225  <20 
B10.BR (H-2 k) GT-TsF  WF8.C2  1,900  <20 
B 10.BR (H-2 h) GT-TsF  WFS.C 12  763  <20 
BI0.BR (H-2 k) GT-TsF  WF8.D1  <20  513 
B10.BR (H-2*) GT-TsF  WF8.D2  863  <20 
Experiment II: test for anti-I-J  b activity in WF9 series 
Control GT-MBSA response  --  251  --  -- 
C57BL/6 (H-2 n) GT-TsF  --  <15  --  -- 
C57BL/6 (H-2 b) GT-TsF  WF9.1.4  735  <15 
C57BL/6 (H-2 b) GT-TsF  WF9.5.2  870  <15 
C57BL/6 (H-2 b) GT-TsF  WF9.11.6  585  <15 
C57BL/6 (14-2  b) GT-TsF  WF9.20.8  488  <15 
C57BL/6 (H-2 b) GT-TsF  WF9.24.8  270  105 
C57BL/6 (H-2 b) GT-TsF  WF9.40.5  998  <15 
*  GT-specific PFC response of BALB/c spleen cells 5 d after culture initiation, each culture containing 2.5 
p,g of GT as GT-MBSA, GT-TsF (1:400 final), or no factor. GT-TsF was incubated on immunoadsorbent 
columns, and effluents were collected.  Columns were washed with PBS, and glycine-HCl, pH  2.5, was 
used to elute bound material. 
:~ Immunoadsorbents prepared from hybridoma culture supernatants (see Materials and Methods). 
§ Effluents from supernatant-Sepharose columns were added at  1:400 final dilution. 
II Bound material was eluted with glycine-HCl buffer, pH 2.5. Eluate was neutralized with 2 M  Tris to pH 
7.2 before addition to culture. 
EXTRACT  IMMI~OADSORBF.NT 
li~.l~C  RESPONSE TO  Gr,'MB~A  IN  VITRO 
,-.  I  I 
too.era (,-,P) m-'r,f 
..-  II 
~  (~.-,-J~  Iiiiiiiiiiiiiiiiiiil 
c~,m,As 0-~) ~-'r.F 
liiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiil 
I  I  I  I  o  ,~  e~  11o  '  i~o 
FIDIICIE~  OF  CON/ilOI.  R~,l~lff~ 
Flo.  2.  Specificity of two anti-I-J mAb. I-J  k (B10.BR)  GT-TsF totally suppresses the GT-MBSA 
response of BALB/c mice. This suppressive activity can be totally removed by WF8.C 12.8  (anti-I- 
jk mAb) but not by WF9.40.5 (anti-I-J  b mAb) immunoadsorbent columns. Conversely, an I-J  b (B6) 
GT-TsF is adsorbed by WF9.40.5 but not by WF8.C 12.8 immunoadsorbent columns. 1576  ANTI-I-J MONOCLONAL ANTIBODIES 
TABLE III 
Absorption of Monoclonal Anti-I-J Antibody Activity by B I O.A ( 3R ) and B I O.A ( 5R )  Lymphocytes 
Strain  Antigen§ 
Additions to culture~ 
Antibody  Absorption 
GT-specific PFC per culture* 
Final anti-I-J dilution 
Con- 
trol  1:  1:  1: 
4,000  40,000  400,000 
B10.BR (H-2 k)  GT-MBSA  --  --  600  --  --  -- 
GT  --  --  217  --  --  -- 
GT  WF8.C12.8  (aI-J k)  None  367  1,365  345 
GT  WF8.C12.8  B10.A(3R)  698  NTll  660 
GT  WF8.C12.8  B10.A(5R)  <15  <15  <15 
C57BL/10  GT-MBSA  --  --  232  --  --  -- 
(H-2 b)  GT  --  --  52  --  --  -- 
GT  WF9.40.5  (al-J b)  None  352  495  190 
GT  WF9.40.5  BI0.A(3R)  <15  <15  90 
GT  WF9.40.5  B10.A(5R)  825  375  712 
* GT-specific  PFC responses on day 5 of culture. 
:]: Sterile ascites  fluid containing monoclonal anti-I-J antibodies was  added  at  culture  initiation  at  the 
indicated final dilutions.  Where indicated, 0.5 ml of ascites was absorbed for 1 h at 4°C with 300 ×  10  s 
spleen and thymus cells, before addition to culture. 
§ 2.5 #g of GT as GT-MBSA or 10/~g of GT was added at culture initiation. Spleen cells, either B10.BR 
or C57BL/10, were cultured for 5 d at 8 ×  106 cells per 0.5 ml in Mishell-Dutton medium containing 5 
×  10  -~ M 2-mercaptoethanol. 
[[ Not tested. 
supernates  were  screened  for  their  effect  on  the  GT  responsiveness  of AKR/Cum 
spleen  cells  in  vitro  (Fig.  1).  Cultures  containing  only  GT  produced  <60  PFC  per 
culture.  A  number  of those  wells receiving hybridoma  culture  supernates  showed  a 
marked  enhancement  of GT-speeific  PFC.  The  great  frequency  with  which  these 
supernates  allow a  GT-suppressor  strain  to  make  a  GT  response,  shown  in  Fig.  1,  is 
most likely due both to the use of hyperimmune  animals in the fusion and to the fact 
that  this  is  a  second-phase  screening  from  preselected  wells.  Subsequent  screenings 
performed  in  this manner  revealed that  some hybridomas  showed  a  more consistent 
pattern  of augmentation  than  others.  Seven of these,  each  indicated  by  an  asterisk, 
were selected for subsequent  testing. 
Adsorption of GT-TsF by Hybridoma Culture Supernates.  Although  indicative of anti-I- 
J  activity, the screening procedure  described  above is by no means  conclusive proof. 
Because determinants  encoded by the I-J subregion  have been shown to be associated 
with soluble TsF (8-10), we wished to establish whether those supernates that augment 
a  PFC  response  in  vitro  can  also  bind  GT-TsF.  Accordingly,  the  heat-inactivated 
immunoglobulin  fractions  of the hybridoma  cultures  indicated  by an  asterisk  in  Fig. 
1 were  coupled  to  CNBr-Sepharose  and  used  as  immunoadsorbent  columns  for  the 
third  screening  phase.  B10.BR  (I-J k)  GT-TsF  was  incubated  on  the  hybridoma 
immunoglobulin-Sepharose  columns.  B10.BR  GT-TsF  normally  causes  near  total 
suppression  of the GT-MBSA  PFC response of BALB/c  spleen cells in vitro at a  1:400 
final dilution (Table II, experiment I). Supernates  from five of the anti-I-J  k hybridoma 
cultures  (WF8  series;  A12,  B6,  C2,  C12,  and  D2)  bound  GT-TsF  and  two  (B2  and 
D1)  did  not.  Adsorbed  GT-TsF  can  be  eluted  from  the  columns  with  glycine-HCl 
buffer,  pH  2.5,  with  no  loss  of  suppressive  activity  (Table  II  and  unpublished CARL  WALTENBAUGH  1577 
observations),  indicating that the loss of suppressive  activity of GT-TsF  when incu- 
bated on the Sepharose columns was not due to the inactivation of GT-TsF  by the 
column  adsorbti0n  procedure.  Monoclonal  cell  lines  were  then established  by  soft 
agar  cloning of the hybridoma cells,  and  the  monoclonally derived  cell  lines were 
rescreened according to the procedures described above. 
Screening procedures for the identification of hybridoma anti-I-J  b antibodies were 
similar to those used for the detection of anti-I-J  k antibodies, except that hybridoma 
culture supernates were  tested on either B6 (I-J b) or B10 (I-J b) spleen cell cultures 
receiving a suboptimal, 5 #g/culture, concentration of GAT, similar to that shown in 
Table I. Six hybridoma-containing wells were further tested for their ability to bind 
I-J  b GT-TsF  (Table II, experiment II). Similar to our findings with the WF8 series of 
TABLE  IV 
Anti-l-J k Antibodies  in AKR and B I O.BR Mice  In  Vivo Activity of Monoclonal 
Number 
Strain*  of mice  Treatment:~  GT-specific PFC 
per spleen§  PII 
per group 
Experiment I 
AKR/Cum (H-2 k)  3  --  3,067  ±  260  -- 
AKR/Cum  7  WF9.11.6 (otI-J b)  4,128  +  688  0.65 
AKR/Cum  7  WF8.A12.4 (otI-J k)  11,842 +  989  <0.01 
AKR/Cum  7  WF8.D2.3 (aI-J k)  8,585  +  782  <0.01 
Experiment II 
B10.BR (H-2 k)  4  --  3,450  ±  1,021  -- 
B10.BR  4  WF8.C12.8 (ctI-J k)  6,888  ±  1,169  0.04 
* Mice were immunized with 100 pg of GT in Maalox and Bordetella pertussis immediately after i.v. injection 
of monoclonal anti-I-J antibodies. 
20 pl of hybridoma culture supernatant  (experiment I) or 20 #g of DEAE-Sephacel-purified antibody 
from ascites fluid was injected i.v. in 0.5 ml HBSS. 
§ 7 d after injection, GT-specific PFC were enumerated. 
II All comparisons made with Student's t test. 
TABLE  V 
Adsorption  of Monoclonal  GT-TsF by Monoclonal  Anti-l-J k Antibody 
Immunoadsorbent:~ 
GT-specific PFC per culture* 
Un o 
Effluent  Eluate 
treated 
Control GT-MBSA response  --  310  --  -- 
WF11.3.A1  (GT-TsF)§  --  <10  --  -- 
WF11.3.A1  WF8.C12.8 (anti-I-J  k)  250  <1011 
Eluate from WF8.C12.811  Anti-CGAT (anti-idiotype)  570  <10 
* GT-specific PFC were counted on day 5 of Mishell-Dutton culture. WF11.3.A1  was incubated with the 
appropriate immunoadsorbent, and the effluent was collected.  The column was washed with PBS, and 
bound material was eluted with glycine-HCl, pH 2.5. The eluate was neutralized with 2 M  Tris to pH 
7.2 before addition to culture. 
:~ Immunoadsorbent columns were prepared as described in Materials and Methods. The anti-CGAT (anti- 
idiotype) columns were generously provided by Dr. S.-T. Ju and Dr. M. Dorf, Harvard Medical School 
§ Monoclonal GT-TsF (WF11.3.A1)  was derived from the fusion of GT-primed B10.BR (H-2 k) spleen cells 
with BW5147.G.  1.4 and added to cultures at a  1:2,000 final concentration. 
I[ Material  eluted  from WF8.C12.8  was neutralized  and  sequentially adsorbed on  an  anti-CGAT  (anti- 
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hybridoma mAb, six of the seven anti-I-J  b mAb anti-I-J  b tested (WF9 series;  1.4, 5.2, 
11.6, 20.8, and 40.5) bound B6 GT-TsF. 
Specificity  of Monoclonal Anti-I-J Antibodies.  The specificity of two anti-I-J  mAb  is 
shown in Fig. 2. An I-J  k GT-TsF is bound by anti-I-J  k mAb (WF8.C12.8) but not by 
anti-I-J  b mAb (WF9.40.5). Conversely, an  I-J  b GT-TsF is bound by WF9.40.5 but not 
by WF8.C 12.8. Table III shows that the in vitro PFC-enhancing ability of WF8.C 12.8 
is completely absorbed by 5R  (I-J k)  spleen and thymus cells but not by 3R  (I-J b) 
lymphoid cells. Similarly WF9.40.5 activity is completely removed by absorption by 
3R but not by 5R spleen and thymus cells.  Together, these data show that these two 
anti-I-J  mAb  are noncross-reactive, indicating that  they do not recognize common 
"framework" portions of I-J b and I-J k gene products. Furthermore, neither the WF8 
nor the WF9 series of hybridoma anti-I-J antibodies cross-reacts with  BALB/c (H- 
2d,I-Jd)-derived  GT-TsF  (unpublished  observation).  Although  cross-reactivity be- 
tween I-J b and I-J a specificities has been reported for alloantiserum  (24)  and, most 
recently, for another anti-I-J  b mAb  (25), we have observed no such cross-reactivity. 
This is not  surprising in  light of the fact that  the WF8  and  WF9 series of anti-I-J 
mAb  were derived from the fusion of hyperimmune spleen cells from F1 mice that 
carried the H-2 d as part of their genome. The use of DBA/2 (H-2d, I-J d) as one of the 
parents  of the  F1  was  purposely  included  to  help  eliminate  this  cross-reactivity. 
Further studies  are currently in  progress to  determine whether these or any other 
anti-I-J mAb are cross-reactive with I-J gene products of"inappropriate" haplotypes. 
In  Vivo Activity  of Anti-I-J k  Monoclonal  Antibodies.  It  remained  to  be  determined 
whether these mAb have in vivo as well as in vitro activity. Table IV, experiment I, 
illustrates that  the intravenous injection of 20 #1 of culture supernate from 2-d-old 
cultures of WF8.A12.4 or WF8.D2.3  (both anti-I-J  k mAb)  into AKR  (H-2  k)  allows 
these mice to make a  significant anti-GT PFC response. Injection of anti-I-J  b mAb 
(WF9.11.6) into AKR mice caused no significant augmentation of the anti-GT PFC 
response. Hybridoma cells were grown in ascites form in irradiated mice. The resultant 
ascites fluid was fractionated with 50% ammonium sulfate, dialyzed, and purified on 
a DEAE-Sephacel column equilibrated with 0.04 M  PO4 buffer, pH 8.2. Experiment 
II shows  that  the intravenous administration  of 20 #1 of this purified mAb  caused 
B 10.BR (H-2  k) mice to respond to GT challenge. Therefore, the anti-I-J k mAb act in 
vivo in much the same manner as alloantisera (12). 
Monoclonal GT-TsF Bears Both I-J and Idiotypic Determinants.  A number of antigen- 
specific TsF have been shown to bear antigenic determinants of the I-J subregion (8- 
10). Several of these extracts from Ts have been shown to have idiotypic determinants 
in  common  with  antibody  (26,  27).  Direct  evidence  that  both  I-J  and  idiotypic 
determinants are present on the same TsF molecule or molecular complex is lacking. 
The establishment of monoclonal cell lines producing TsF allows us to resolve this 
question.  Monoclonal GT-TsF was  produced by a  hybridoma T  cell line resulting 
from  the  fusion  of BW5147.G.1.4  (HAT-sensitive) AKR  thymoma cells  with  GT- 
primed  B10.BR  (I-J k)  spleen cells.  Culture supernates containing GT-TsF derived 
from the resultant hybridoma T  cell line WF11.3.A1  are able to totally suppress the 
GT-MBSA PFC response of BALB/c spleen cells in vitro at a  1:2,000 final dilution 
(Table V). This suppressive material can be adsorbed by and eluted from a  mono- 
clonal  anti-I-J  k  (WF8.C12.8)  immunoadsorbent  column.  Recently, Ju  et  al.  (22) 
described an anti-idiotype antibody (termed anti-CGAT) that recognizes the predom- CARL  WALTENBAUGH  1579 
inant  idiotypic determinants on anti-GAT and  anti-GT antibodies.  Because initial 
studies  showed  that  our  monoclonal  GT-TsF specifically binds  to  GT-Sepharose 
columns, we asked whether WF 11.3.A 1-derived GT-TsF bears idiotypic determinants 
recognized by anti-CGAT anti-idiotype antibodies. The suppressive material eluted 
from the WF8.C 12.8 immunoadsorbent column (Table V) was incubated on an anti- 
CGAT column.  Table V  shows  that  our monoclonal GT-TsF, which  is bound  by 
anti-I-J  ~ mAb,  is also bound by and can be eluted from the anti-idiotype column. 
Therefore, the same monoclonal GT-TsF bears both I-J and idiotypic determinants. 
Studies are currently in progress to determine the biochemical association of these 
two determinants. 
Discussion 
I-J subregion genes or their products appear to be intimately involved in several 
aspects of immune regulation. The marker locus for the 1-J subregion, Ia-4, codes for 
antigenic determinants on Ts and TsF  (7-10,  24), whereas other Ia  loci contained 
within the I-J subregion apparently code for determinants found on Th and macro- 
phages  (7).  The selective expression of different I-J  gene products on  functionally 
distinct populations of lymphocytes and macrophages provides a potentially powerful 
model  for the  investigation  of genetic  regulation  of the  immune  response.  Major 
drawbacks to such studies have been both the limited availability of adequate anti- 
I-J alloantisera  (28)  and  the relative heterogeneity of such sera with  respect to/-jr 
gene products (14). Lack of intra-I-J recombinant mouse strains also hinders definition 
of additional Ia loci and/or gene products within the subregion. A promising approach 
to the identification of/-region gene products is to use monoclonal antibodies (mAb) 
directed against  individual  antigenic determinants.  I  report the establishment  of a 
panel of mAb directed against  gene products of the l-J a and I-J ~ subregions. These 
mAb are secreted by hybridoma B cell lines derived from the fusion of the P3X63Ag8 
myeloma cell line with either (DBA/2  ×  3R)F1 anti-5R or (DBA/2 ×  5R)  anti-3R 
hyperimmune spleen cells. The resultant hybridoma antibodies were assayed in a two- 
stage functional assay procedure. Putative anti-I-J antibodies were first assayed for 
their ability to augment a humoral immune (PFC) response both in vitro and in vivo. 
The  anti-I-J  mAb  are  active  in  causing  nonresponder  mice,  or  mice  receiving 
suboptimal concentrations of antigen, to respond to antigenic challenge both in vivo 
and in vitro. A select number of these mAb were tested in a second-stage functional 
assay for their ability to bind I-J-bearing GT-TsF. Some of the anti-I-J mAb bind 
TsF, indicating that they may recognize different I-J gene products. Our anti-I-J mAb 
are all of the IgG1 class of antibody and are haplotype specific. No cross-reaction is 
seen between antibodies directed against the I-J b and 1=] 4 subregions. Although cross- 
reactivity by anti-I-J  b antibodies  to  I-J b and  I-J d  subregion  specificities has  been 
reported  (24,  25),  I  have observed no such cross reactivity with either the WF8  or 
WF9 series of mAb (unpublished observations). The lack of cross-reactivity with I-J  b 
products by our anti-I-J  b mAb is most likely due to the use of (H-2 a ×  H-2~)F1 mice 
as one of the fusion partners. Further studies are currently in progress to determine 
whether either the anti-I-J  k or anti-I-J  b mAb cross-react with other I-J specificities. 
The two-stage functional screening assay for the identification of anti-I-J mAb is 
both simple and rapid. Furthermore, in those lacking the appropriate recombinational 
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anti-I-J hybridoma antibodies can be selected using this technique. We are currently 
producing a  panel of mAb  directed against  the I-ri d  subregion.  Our approach  has 
been to hyperimmunize (D2.GD ×  5R)FI mice with B 10.D2 spleen and thymus cells. 
AIIoantisera produced from this immunization combination should recognize I-B d, 
I-ff d,  and I-E d  subregions.  Using the two-stage functional screening assay, we have 
been  able  to  isolate  a  series  of hybridoma  anti-I-J  d antibodies.  We  are  presently 
establishing thes  e as monoclonal hybridoma cell lines by soft-agar cloning techniques. 
The characterization and functional properties of this series of anti-I-J  d mAb will be 
the subject of a forthcoming report.  2 
I-J  gene products have been shown  to be present  on antispecific TsF  (8-10).  In 
addition, intravenous administration of microliter quantities of alloanti-I-J antibodies 
to mice has been shown to augment humoral  (I I,  12)  and cellular  (13)  immunity, 
apparently  through  the  inactivation  of Ts.  There  is  no  evidence  that  antibodies 
directed against I-J determinants on antigen-specific TsF are the same as those that 
augment an immune response. Our experiments show that anti-I-J mAb that binds 
TsF also causes augmentation of a PFC response (Table II and Fig.  I). This is not to 
say, however, that all hybridoma anti-I-J antibodies both augment a humoral response 
and bind TsF. Table II, experiment I, clearly shows that of seven hybridoma anti-I-J 
antibodies, all of which cause augmentation of the GT PFC response in vitro, only 
five bind  I-J  k GT-TsF. This suggests  that  alIoantisera contain  antibodies  directed 
against several different I-J  gene products that are individually recognized by anti-I- 
J  mAb.  That some mAb bind TsF and  augment  the PFC response might indicate 
that these antibodies are directed against  gene products expressed at only one stage 
in  the  suppressor  pathway  (i.e.,  the  anti-I-J  mAb  might  be  directed  against  gene 
products expressed on the TsF-producing [Tsl] ceil). Those mAb that augment a PFC 
response but do not bind TsF may be directed against  I-J determinants selectively 
expressed by a different subset of ceils, representing another stage in the suppressive 
pathway.  The  use  of anti-I-J  mAb  should  allow  the  further  elucidation  of the 
suppressor pathway. 
Little is known about the biochemistry of l-ff  gene products. Monoclonal anti-I-J 
antibodies should provide a  valuable tool in the biochemical characterization of l-ff 
gene products. We have been successful in producing monoclonal GT-TsF by fusing 
spleen ceils from GT-primed BI0.BR (I-ff k)  mice with the BW5147 thymoma. Table 
V shows that the culture supernate from one such hybridoma T  cell line, WFI 1.3.AI, 
contains  a  suppressive material  that  can  be sequentially bound  by anti-I-J  k mAb 
(WF8.C12.8)  and  by  anti-idiotype  (anti-CGAT).  This  clearly  demonstrates  that 
monoclonal GT-TsF bears both I-J  k and idiotypic determinants on the same molecule 
or molecular complex. The use of both monoclonal GT-TsF and anti-I-J mAb should 
provide powerful tools in the further biochemical and functional characterization of 
a functional I-ff gene product. 
Finally, it should be noted that evidence accumulating from other laboratories that 
have been assaying our monoclonal anti-I-J antibodies has demonstrated that  they 
are cytotoxic for azobenzene arsonate Tsl  cells and that they bind Ars-specific TsF 
(J.  Bromberg and  M.  I.  Greene, personal  communication).  These mAb  also  react 
strongly with TsF-producing T  cell hybridoma ceil surface antigens as detected by 
immunofluorescent  staining  (J.  Trial  and J.  A.  Kapp,  personal  communication). 
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Therefore, it appears that  anti-I-J  mAb  are useful in the identification of I-J gene 
products in antigenic systems other than GT and that these antibodies might prove 
to be a  powerful tool for the further delineation of I-J subregion gene(s)  and  their 
products. 
Summary 
Using a novel, two-step functional screening procedure, we have isolated hybridoma 
B cell lines secreting monoclonal antibodies directed against gene products of the I-J b 
and I-J k subregions of the mouse H-2 complex. These monoclonal antibodies act in 
vitro  by  allowing  nonresponder  spleen  cells  to  respond  to  normally  suppressive 
quantities of poly(Glu~Tyr  5°)  (GT)  (WF8 series of anti-I-J  k monoclonal antibodies) 
or  to  suboptimal  concentration  of poly(Glu~°Ala~Fyr  l°)  (WF9  series  of anti-I-J  b 
monoclonal antibodies). Some of the culture supernates that show augmenting activity 
bind  GT-specific T  cell-derived suppressor  factor  (GT-TsF), indicating  that  some 
monoclonal antiantibodies display a nonspecific enhancing effect, or, more likely, that 
anti-I-J  monoclonal  antibodies  have  been  produced  against  I-J  determinants  not 
found on TsF. It is this last possibility that is most intriguing and that might serve as 
a  means for exploring the heterogeneity of the I-J subregion. It is also possible that 
some  of our  monoclonal  anti-I-J  antibodies  might  detect  antigenic  determinants 
selectively expressed on suppressor T  cells, helper T  cells, and/or macrophages.  In 
addition, we have demonstrated that monoclonal anti-I-J antibodies should be useful 
in the biochemical characterization and purification of a monoclonal GT-TsF. These 
haplotype-specific anti-I-J monoclonal antibodies should prove to be powerful tools 
for future studies exploring the role of I-J gene products in the regulation of specific 
immune responses. 
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